GERAGHTY JAMES A has filed 7 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 36000 shares of Fulcrum Therapeutics, Inc. ($FULC) on June 26, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2025 | Fulcrum Therapeutics, Inc. | $FULC | GERAGHTY JAMES A | Not found | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 61,984 | 9999.99% | 58.08% |
| June 3, 2025 | Voyager Therapeutics, Inc. | $VYGR | GERAGHTY JAMES A | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 58,349,769 | 9999.99% | 0.04% |
| Dec. 12, 2024 | PALVELLA THERAPEUTICS, INC. | $PVLA | GERAGHTY JAMES A | Director | D | Series F Preferred Stock, par value $0.001 per share | 1 | $0.01 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 7, 2024 | PALVELLA THERAPEUTICS, INC. | $PVLA | GERAGHTY JAMES A | Director | P | Series F Preferred Stock, par value $0.001 per share | 1 | $1.00 | 1.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Fulcrum Therapeutics, Inc. | $FULC | GERAGHTY JAMES A | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 61,310 | 9999.99% | 48.93% |
| June 5, 2024 | Voyager Therapeutics, Inc. | $VYGR | GERAGHTY JAMES A | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 57,117,046 | 9999.99% | 0.04% |
| June 6, 2023 | Voyager Therapeutics, Inc. | $VYGR | GERAGHTY JAMES A | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 42,161,326 | 9999.99% | 0.05% |